De novo and inherited pathogenic variants in collagen-related osteogenesis imperfecta

被引:13
作者
Zhytnik, Lidiia [1 ]
Maasalu, Katre [1 ,2 ]
Binh Ho Duy [3 ]
Pashenko, Andrey [4 ]
Khmyzov, Sergey [4 ]
Reimann, Ene [5 ,6 ]
Prans, Ele [6 ]
Koks, Sulev [7 ,8 ]
Martson, Aare [1 ,2 ]
机构
[1] Univ Tartu, Dept Traumatol & Orthoped, Tartu, Estonia
[2] Tartu Univ Hosp, Clin Traumatol & Orthoped, Tartu, Estonia
[3] Hue Univ, Hue Univ Med & Pharm, Hue, Vietnam
[4] AMS Ukraine, Dept Pediat Orthoped, Sytenko Inst Spine & Joint Pathol, Kharkov, Ukraine
[5] Univ Tartu, Ctr Translat Med, Tartu, Estonia
[6] Univ Tartu, Dept Pathophysiol, Tartu, Estonia
[7] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia
[8] Univ Western Australia, Perron Inst Neurol & Translat Sci, Perth, WA, Australia
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 03期
基金
欧盟地平线“2020”;
关键词
bone fragility; collagen; de novo; osteogenesis imperfecta; Sanger sequencing; COL1A1; GENE; I COLLAGEN; MUTATIONS;
D O I
10.1002/mgg3.559
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Osteogenesis imperfecta (OI) is a rare genetic bone fragility disorder. In the current study, differences between the genotypes and phenotypes of de novo and inherited collagen-related OI were investigated. Methods A comparative analysis was performed of the genotypes and phenotypes of 146 unrelated inherited and de novo collagen I OI cases from Estonia, Ukraine, and Vietnam. Mutational analysis of the subjects and all available parents were performed with Sanger sequencing. Results Results showed that 56.16% of the OI cases were caused by de novo pathogenic variants. The proportion of OI types OI1, OI4, and OI3 among subjects with inherited OI was 45.31%, 46.88%, and 7.81%, respectively. Among subjects with de novo OI, the proportions of OI types (OI1, OI4, and OI3) were almost equal. Both inherited and de novo OI pathogenic variants occurred more often in the COL1A1 gene than in the COL1A2. The majority of de novo cases were missense pathogenic variants, whereas inherited OI was mostly caused by loss of function pathogenic variants. Conclusion In summary, there were significant differences between the phenotypes and genotypes of subjects with de novo and inherited OI. These findings may promote the further understanding of OI etiology, and assist with diagnostics procedures, as well as with family planning.
引用
收藏
页数:11
相关论文
共 27 条
  • [1] New insights into the generation and role of de novo mutations in health and disease
    Acuna-Hidalgo, Rocio
    Veltman, Joris A.
    Hoischen, Alexander
    [J]. GENOME BIOLOGY, 2016, 17
  • [2] Genotype-Phenotype Correlations in Autosomal Dominant Osteogenesis Imperfecta
    Ben Amor, I. Mouna
    Glorieux, Francis H.
    Rauch, Frank
    [J]. JOURNAL OF OSTEOPOROSIS, 2011, 2011
  • [3] Bonod-Bidaud C., 2013, GENETIC MANIPULATION
  • [4] BYERS PH, 1992, ANNU REV MED, V43, P269, DOI 10.1146/annurev.me.43.020192.001413
  • [5] Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
    Chen, Rui
    Mias, George I.
    Li-Pook-Than, Jennifer
    Jiang, Lihua
    Lam, Hugo Y. K.
    Chen, Rong
    Miriami, Elana
    Karczewski, Konrad J.
    Hariharan, Manoj
    Dewey, Frederick E.
    Cheng, Yong
    Clark, Michael J.
    Im, Hogune
    Habegger, Lukas
    Balasubramanian, Suganthi
    O'Huallachain, Maeve
    Dudley, Joel T.
    Hillenmeyer, Sara
    Haraksingh, Rajini
    Sharon, Donald
    Euskirchen, Ghia
    Lacroute, Phil
    Bettinger, Keith
    Boyle, Alan P.
    Kasowski, Maya
    Grubert, Fabian
    Seki, Scott
    Garcia, Marco
    Whirl-Carrillo, Michelle
    Gallardo, Mercedes
    Blasco, Maria A.
    Greenberg, Peter L.
    Snyder, Phyllis
    Klein, Teri E.
    Altman, Russ B.
    Butte, Atul J.
    Ashley, Euan A.
    Gerstein, Mark
    Nadeau, Kari C.
    Tang, Hua
    Snyder, Michael
    [J]. CELL, 2012, 148 (06) : 1293 - 1307
  • [6] Point mutations as a source of de novo genetic disease
    de Ligt, Joep
    Veltman, Joris A.
    Vissers, Lisenka E. L. M.
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2013, 23 (03) : 257 - 263
  • [7] Collagens -: structure, function, and biosynthesis
    Gelse, K
    Pöschl, E
    Aigner, T
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (12) : 1531 - 1546
  • [8] The clinical features of osteogenesis imperfecta in Vietnam
    Ho Duy Binh
    Maasalu, Katre
    Dung, Vu Chi
    Bich Ngoc, Can T.
    Ton That Hung
    Nam, Tran V.
    Thanh Nhan, Le N.
    Prans, Ele
    Reimann, Ene
    Zhytnik, Lidiia
    Koks, Sulev
    Martson, Aare
    [J]. INTERNATIONAL ORTHOPAEDICS, 2017, 41 (01) : 21 - 29
  • [9] Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta
    Binh Ho Duy
    Zhytnik, Lidiia
    Maasalu, Katre
    Kandla, Ivo
    Prans, Ele
    Reimann, Ene
    Martson, Aare
    Koks, Sulev
    [J]. HUMAN GENOMICS, 2016, 10 : 27
  • [10] ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta
    Lisse, Thomas S.
    Thiele, Frank
    Fuchs, Helmut
    Hans, Wolfgang
    Przemeck, Gerhard K. H.
    Abe, Koichiro
    Rathkolb, Birgit
    Quintanilla-Martinez, Leticia
    Hoelzlwimmer, Gabriele
    Helfrich, Miep
    Wolf, Eckhard
    Ralston, Stuart H.
    de Angelis, Martin Hrabe
    [J]. PLOS GENETICS, 2008, 4 (02):